Remdesivir is approved by Anvisa to treat Covid-19; know the details
Remdesivir is approved by Anvisa to treat Covid-19; know the details The first antiviral to be recommended for patients with Covid-19 in the package insert is remdesivir, approved this Friday (12th) by the National Health Surveillance Agency (Anvisa). The agency also granted definitive registration for Covishield , the vaccine developed by AstraZeneca in partnership with the University of Oxford, in the United Kingdom. With this release, the immunizer can be used in the general population. According to Raphael Sanches Pereira, specialist in the quality management of medicines at Anvisa, the application for approval of remdesivir was submitted to the agency on August 6, 2020. “After that, we had some conversations to better understand because it is a drug developed with great speed. and many aspects are not yet closed ”, he explains. The formula will have the trade name of Veklury and will be sold in the form of “powder for solution for injection” that must be re...